Cite
HARVARD Citation
Rodriguez, M. et al. (n.d.). 1492. Targeted Substitution of Omadacycline in Place of Standard of Care for CABP Treatment is Associated with a Risk Reduction of Clostridioides difficile Infection and Financial Cost Savings in the Acute Care Setting. Open forum infectious diseases. pp. S747-S748. [Online].